Get Started

ACTU

NASD Actuate Therapeutics, Inc.
Nov 6, 2026 · 8:19 AM ET LAST TRADE Market Closed

$0.3201 ↓ -0.0069 (-2.11%) Trading Down from the previous close of $0.3270

YTD change
-94.77%
vs 20-day SMA
-32.14%
vs 200-day SMA
-84.41%

Price ranges

Previous day
$0.3195 $0.3698
open $0.3550 close $0.3270
-$0.0280 (-7.89%)
Today
$0.0000 $0.0000
$0.3201
Past week
$0.3195 $0.3850
from $0.3710 now $0.3201
-$0.0509 (-13.72%)
Past month
$0.3195 $0.7099
from $0.6790 now $0.3201
-$0.3589 (-52.86%)
This year
$0.3195 $7.0499
from $6.1200 now $0.3201
-$5.7999 (-94.77%)

Price & Performance

-2.66 (-89.06%) / 6M

$0.0860$1.25$2.42$3.58May 6Aug 6Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.3% away from all-time highs of $11.9900
  • ACTU is down 95% since the beginning of the year
  • ACTU is down 95% over the past 12 months
  • ACTU is down 53% over the past 1 month
  • 5% of all ACTU investors are betting against ACTU

ACTU reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -94.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.2
Earnings momentum -17.6% Quarterly EPS growth
Quarterly change -17.6%

Valuation

P/E ratio N/A
Enterprise value $3.8M
Beta 1.53

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$4.4M
Debt$405.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $17.6M

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,364.73 -3.76%
JNJ Johnson & Johnson $272.32 -1.45%
ABBV AbbVie, Inc. $288.24 -2.24%
MRK Merck & Co., Inc. $146.94 -2.27%
RHHBY Roche Holding Ltd Sponsored ADR $59.45 -2.45%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.